Slackia equolifaciens was isolated from human feces. It is an equol-producing bacterium.
For Research Use Only. Not intended for use in food manufacturing or medical procedures (diagnostics or therapeutics). Do Not Use in Humans.
Product Information
Product Overview
Slackia equolifaciens was isolated from human feces. It is an equol-producing bacterium.
Target
Eggerthellaceae
Genus
Slackia
Strain Designation
DZE
Application
Study and research
Culture Medium
GAM
Culture Conditions
37°C; Anaerobic
Source
Human feces
Risk Group
1
Product Format
Freeze-dried
Packaging
Ampoule tube
Storage
-80°C
Shelf Life
6 years
Target Introduction
Introduction
The Eggerthellaceae are a family of Gram-positive, rod- or coccus-shaped Actinobacteria. It is the sole family within the order Eggerthellales. Members of this family are mostly anaerobic, non-motile, asaccharolytic and do not form spores. Eggerthellaceae species are commonly isolated from human and animal faeces and other human sources such as the colon, vagina, oral cavity and blood.
Alternative Names
Slackia equolifaciens
FAQs Customer Reviews Related Products
What are the optimal growth conditions for Slackia equolifaciens?
Slackia equolifaciens thrives under anaerobic conditions at 37°C. Using a nutrient-rich medium such as GAM supplemented with additional growth factors ensures optimal bacterial growth and viability for research applications.
How is Slackia equolifaciens introduced into animal models for research purposes?
Slackia equolifaciens is typically administered to animal models via oral gavage, allowing for precise dosage and delivery. This method enables researchers to study its effects on gut microbiota composition and host health in a controlled experimental environment.
How can the metabolic activity of Slackia equolifaciens be studied?
The metabolic activity of Slackia equolifaciens can be studied using techniques such as gas chromatography-mass spectrometry (GC-MS) and high-performance liquid chromatography (HPLC) to analyze the production of metabolites, including equol. These methods help in understanding the metabolic pathways and their implications for human health.
How can the presence of Slackia equolifaciens be confirmed in experimental samples?
The presence of Slackia equolifaciens can be confirmed using molecular techniques such as 16S rRNA gene sequencing or species-specific PCR assays. These methods provide accurate identification and quantification of the bacterium in various samples.
How can the probiotic effects of Slackia equolifaciens be evaluated in vitro?
The probiotic effects of Slackia equolifaciens can be evaluated in vitro using co-culture systems with intestinal cell lines. Researchers can monitor changes in cell viability, cytokine production, and barrier function to assess the bacterium's beneficial properties.
Exceptional Research Tool Slackia equolifaciens from Creative Biolabs significantly enhanced our metabolic studies, providing precise and reliable data, essential for our research.
Superior Consistency
The superior consistency of Slackia equolifaciens greatly improved our microbiome analysis, making it a preferred choice for our lab experiments.
Enhanced Experimental Efficiency
Incorporating Slackia equolifaciens into our experiments improved research efficiency, allowing us to achieve faster and more accurate results.
Outstanding Research Value
The outstanding value of Slackia equolifaciens in enhancing our experimental workflows makes Creative Biolabs our go-to provider.
Reliable Experimental Results Slackia equolifaciens consistently delivered reliable outcomes in our drug development projects, providing dependable data for our team.
Click the button below to contact us or submit your feedback about this product.
